The resistance of JAK2V617F cells to TGF‐β could be due to a reduced TGF‐β signalling in MPN HSPCs (intrinsic mechanism), or the secretion of TGF‐β inhibitors by cells from the microenvironment. This evidence concerns the gene TGFB1 and myeloproliferative disorder.